Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323635 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT00323635 is a Phase 4 study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 19 participants.
The verdict
NCT00323635, a Phase 4 study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study is being done to compare frequency of urination during the night when women take tolterodine tablets vs. when they take placebo tablets. We will also measure whether between these two treatment conditions there are any differences in women's sleep, mood and performance on cognitive tests.
Interventions
- DRUG tolterodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00323635
The ClinicalTrials.gov registry entry for NCT00323635 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tolterodine is the first listed.
NCT00323635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00323635 about?
NCT00323635 is a clinical study titled "A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.". This study is being done to compare frequency of urination during the night when women take tolterodine tablets vs. when they take placebo tablets. We will also measure whether between these two treatment conditions there are any differences in women's sleep, mood and performance on cognitive tests...
What is the current status of trial NCT00323635?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2006-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00323635?
The interventions under investigation include: tolterodine (DRUG).
Who is sponsoring clinical trial NCT00323635?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.